MedTrace Logo

Creatine Monohydrate as Adjuvant Therapy for Bipolar Depression

NCT01655030 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2023-12-05

No results posted yet for this study

Summary

The purpose of this study is to determine whether creatine monohydrate is effective as an adjuvant treatment for bipolar depression.

Conditions

Interventions

DIETARY_SUPPLEMENT

creatine monohydrate

DIETARY_SUPPLEMENT

placebo

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Beny Lafer, PhD · Bipolar Disorder Research Program, Coordinator, IPq-HC-FMUSP

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01655030 on ClinicalTrials.gov